EuroEspes Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Public

  • Employees
  • 26

Employees

  • Stock Symbol
  • EEP

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.54
  • (As of Thursday Closing)

EuroEspes General Information

Description

Euroespes SA is a biomedical research center offering medical, research, medical informatics and bioinformatics services. It offers medicine and personalized treatment for central nervous system disorders and researches genomic medicine. Other services offered by the company include genomics, digital diagnosis, diagnostic imaging, neuro-psychology, neuro-ophthalmology, nursing, epigenetics, clinical analysis and otorhinolaryngology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Santa Marta de Babío
  • Bergondo
  • 15165 A Coruna
  • Spain
+34 981
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Other Healthcare Services
Stock Exchange
MAD
Vertical(s)
Corporate Office
  • Santa Marta de Babío
  • Bergondo
  • 15165 A Coruna
  • Spain
+34 981

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EuroEspes Stock Performance

As of 27-Oct-2022, EuroEspes’s stock price is $0.54. Its current market cap is $6.32M with 11.6M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.54 $0.54 $0.51 - $0.65 $6.32M 11.6M 3.79K -$0.02

EuroEspes Financials Summary

As of 31-Dec-2025, EuroEspes has a trailing 12-month revenue of $3.25M.

In Thousands,
USD
TTM 31-Dec-2025 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
Revenue 3,251 3,251 3,148 3,196
EBITDA 747 747 498 (991)
Net Income 1 1 (350) (2,309)
Total Assets 7,544 7,544 7,225 8,769
Total Debt 3,537 3,537 3,621 4,454
Public Fundamental Data provided by Morningstar, Inc. disclaimer

EuroEspes Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EuroEspes‘s full profile, request access.

Request a free trial

EuroEspes Patents

EuroEspes Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2763025-T3 Bioactive extract obtained from vicia faba and its use in the treatment and / or prevention of neurodegenerative diseases Active 29-Mar-2016
EP-3225245-A1 Bioactive extract obtained from vicia faba and its use in the treatment and/or prevention of neurodegenerative diseases Active 29-Mar-2016
EP-3225245-B1 Bioactive extract obtained from vicia faba and its use in the treatment and/or prevention of neurodegenerative diseases Active 29-Mar-2016
ES-2128265-B1 Genetic kit for the molecular characterization of alzheimer's disease. Inactive 04-Jun-1997
ES-2128970-B1 Method of obtaining cultures of microglial cells of adult rat and its applications. Inactive 20-Feb-1997
To view EuroEspes’s complete patent history, request access »

EuroEspes Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EuroEspes Investments & Acquisitions (2)

EuroEspes’s most recent deal was a Merger/Acquisition with EuroEspes Biotecnología. The deal was made on 01-Aug-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
EuroEspes Biotecnología 01-Aug-2014 Merger/Acquisition Other Pharmaceuticals and Biotechnology
EuroEspes Biotecnología Corporate Other Pharmaceuticals and Biotechnology
To view EuroEspes’s complete investments and acquisitions history, request access »

EuroEspes ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Services

Subindustry

Rank

Percentile

To view EuroEspes’s complete esg history, request access »

EuroEspes FAQs

  • When was EuroEspes founded?

    EuroEspes was founded in 1991.

  • Where is EuroEspes headquartered?

    EuroEspes is headquartered in A Coruna, Spain.

  • What is the size of EuroEspes?

    EuroEspes has 26 total employees.

  • What industry is EuroEspes in?

    EuroEspes’s primary industry is Biotechnology.

  • Is EuroEspes a private or public company?

    EuroEspes is a Public company.

  • What is EuroEspes’s stock symbol?

    The ticker symbol for EuroEspes is EEP.

  • What is the current stock price of EuroEspes?

    As of 27-Oct-2022 the stock price of EuroEspes is $0.54.

  • What is the current market cap of EuroEspes?

    The current market capitalization of EuroEspes is $6.32M.

  • What is EuroEspes’s current revenue?

    The trailing twelve month revenue for EuroEspes is $3.25M.

  • What is EuroEspes’s annual earnings per share (EPS)?

    EuroEspes’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process